Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran vs phenprocoumon for LV thrombus after STEMI
2022-500383-35-00Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute ST-segment elevation myocardial infarction (STEMI), Left ventricular thrombosis (LVT) and brain infarction comparing Dabigatran arm with Phenprocoumon arm (2 arms). Started May 2024; status: completed.
02
Drugs
dabigatranphenprocoumon
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)Left ventricular thrombosis (LVT)brain infarction
Beyond the preview
Go deeper on 2022-500383-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500383-35-00.